AbbVie
ABBV
#28
Rank
NZ$531.85 B
Marketcap
$300.66
Share price
1.62%
Change (1 day)
5.28%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $5.98

According to AbbVie's latest financial reports the company's current EPS (TTM) is $6.15. In 2022 the company made an earnings per share (EPS) of $11.13 an increase over its 2021 EPS that were of $10.84.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.98-46.28%
2022$11.132.63%
2021$10.84125.21%
2020$4.81-45.69%
2019$8.8648.35%
2018$5.977.6%
2017$5.55-9.3%
2016$6.1215.48%
2015$5.30185.53%
2014$1.86-57.11%
2013$4.33-21.69%
2012$5.5355.73%
2011$3.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.11-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.63 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.07 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.65 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.34 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.85 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.85-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.32-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.28-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA